BROOKS LAB LIMITED Share Price

NSE

Company Profile


Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to the critical care segment in the parental section such as Beta Lactam Cephalosporin and General Dry Powder Injectables, Ampoules and Liquid Vials and Dry Syrups and Tablets. As of 2010, its product portfolio consist of 26 dry powder injections, 31 liquid injections, five tablets and two dry syrups. It manufactures a range of products on third party basis for companies such as Zydus Cadila, Alembic, Intas, Wockhardt, Alkem, VHB, Medley, Biochem, JB Chemical, PDPL and Sanat. Its carbapenems products include Inj Ertapenem and Inj Meropenem. Its liquid injectables include Inj Nandrolone, Decanoate, Inj Aceclofenac and Inj Midazolam.

Return Calculator

This tools helps you project your potential returns on investments for the given stock, for a specified amount over a pre-defined period of time.

Invested amount

Investment period

1 year
2 year
5 year
=
up down
Returns
CAGR
%